Chetana Lim1, Chady Salloum1, Antonella Tudisco2, Claudio Ricci3, Michael Osseis1, Niccolo Napoli2, Eylon Lahat4, Ugo Boggi2, Daniel Azoulay5,6. 1. Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Henri Mondor Hospital, 51 Avenue de Lattre de Tassigny, 94010, Créteil, France. 2. Division of General and Transplant Surgery, Cisanello Hospital, Pisa, Italy. 3. Department of Internal Medicine and Surgery (DIMEC), S. Orsola-Malpighi Hospital, Alma Mater Studiorum-University of Bologna, Bologna, Italy. 4. Department of General Surgery and Transplantation, Hepatobiliary and Pancreatic Surgery, Tel Hashomer Hospital, Tel Aviv, Israel. 5. Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Henri Mondor Hospital, 51 Avenue de Lattre de Tassigny, 94010, Créteil, France. daniel.azoulay@aphp.fr. 6. Department of General Surgery and Transplantation, Hepatobiliary and Pancreatic Surgery, Tel Hashomer Hospital, Tel Aviv, Israel. daniel.azoulay@aphp.fr.
Abstract
OBJECTIVES: A laparoscopic approach improves short-term outcomes and maintains long-term outcomes compared to an open approach. In turn, the recent development of robotic surgery raises the question whether it performs as well as laparoscopic surgery. The aim of this study was to compare the short- and long-term outcomes of laparoscopic liver resection (LLR) and robotic liver resection (RLR) for malignancies. METHOD: From 2011 to 2017, the study population included 111 patients in the LLR group and 61 in the RLR group. Short- and long-term outcomes were compared before and after propensity score matching (PSM). RESULTS: Operative mortality rate was nil. The intraoperative blood transfusion rate was higher during RLR (15% vs. 2%, p = 0.0009). Major morbidity and hospital stay were not different between the two groups. The resection margin width (LLR 7 mm vs. RLR 10 mm, p = 0.13) and R1 resection rates (resection margin width < 1 mm; LLR 15% vs. RLR 11%, p = 0.49) were similar. After PSM (55 patients in each group), the blood transfusion, major morbidity, hospital stay and R1 resection were similar between the two groups. When considering the largest subset of patients with hepatocellular carcinoma including 114 patients (66%), the 3-year overall survival rate was 80% in the LLR group and 97% in the RLR group (p = 0.10) and remained similar after PSM (p = 0.27). The 3-year recurrence-free survival rate was 50% in the LLR group and 64% in the RLR group (p = 0.30) and remained similar after PSM (p = 0.26). CONCLUSIONS: No differences were found in blood transfusion, incidence of positive resection margins and long-term outcomes between the two techniques. RLR does not compromise short-term and oncologic outcomes in patients with liver cancers.
OBJECTIVES: A laparoscopic approach improves short-term outcomes and maintains long-term outcomes compared to an open approach. In turn, the recent development of robotic surgery raises the question whether it performs as well as laparoscopic surgery. The aim of this study was to compare the short- and long-term outcomes of laparoscopic liver resection (LLR) and robotic liver resection (RLR) for malignancies. METHOD: From 2011 to 2017, the study population included 111 patients in the LLR group and 61 in the RLR group. Short- and long-term outcomes were compared before and after propensity score matching (PSM). RESULTS: Operative mortality rate was nil. The intraoperative blood transfusion rate was higher during RLR (15% vs. 2%, p = 0.0009). Major morbidity and hospital stay were not different between the two groups. The resection margin width (LLR 7 mm vs. RLR 10 mm, p = 0.13) and R1 resection rates (resection margin width < 1 mm; LLR 15% vs. RLR 11%, p = 0.49) were similar. After PSM (55 patients in each group), the blood transfusion, major morbidity, hospital stay and R1 resection were similar between the two groups. When considering the largest subset of patients with hepatocellular carcinoma including 114 patients (66%), the 3-year overall survival rate was 80% in the LLR group and 97% in the RLR group (p = 0.10) and remained similar after PSM (p = 0.27). The 3-year recurrence-free survival rate was 50% in the LLR group and 64% in the RLR group (p = 0.30) and remained similar after PSM (p = 0.26). CONCLUSIONS: No differences were found in blood transfusion, incidence of positive resection margins and long-term outcomes between the two techniques. RLR does not compromise short-term and oncologic outcomes in patients with liver cancers.
Authors: Go Wakabayashi; Daniel Cherqui; David A Geller; Joseph F Buell; Hironori Kaneko; Ho Seong Han; Horacio Asbun; Nicholas OʼRourke; Minoru Tanabe; Alan J Koffron; Allan Tsung; Olivier Soubrane; Marcel Autran Machado; Brice Gayet; Roberto I Troisi; Patrick Pessaux; Ronald M Van Dam; Olivier Scatton; Mohammad Abu Hilal; Giulio Belli; Choon Hyuck David Kwon; Bjørn Edwin; Gi Hong Choi; Luca Antonio Aldrighetti; Xiujun Cai; Sean Cleary; Kuo-Hsin Chen; Michael R Schön; Atsushi Sugioka; Chung-Ngai Tang; Paulo Herman; Juan Pekolj; Xiao-Ping Chen; Ibrahim Dagher; William Jarnagin; Masakazu Yamamoto; Russell Strong; Palepu Jagannath; Chung-Mau Lo; Pierre-Alain Clavien; Norihiro Kokudo; Jeffrey Barkun; Steven M Strasberg Journal: Ann Surg Date: 2015-04 Impact factor: 12.969
Authors: Mikhail Efanov; Ruslan Alikhanov; Victor Tsvirkun; Ivan Kazakov; Olga Melekhina; Pavel Kim; Andrey Vankovich; Konstantin Grendal; Stanislav Berelavichus; Igor Khatkov Journal: HPB (Oxford) Date: 2017-06-07 Impact factor: 3.647
Authors: Rachel E Beard; Sidrah Khan; Roberto I Troisi; Roberto Montalti; Aude Vanlander; Yuman Fong; T Peter Kingham; Thomas Boerner; Eren Berber; Bora Kahramangil; Joseph F Buell; John B Martinie; Dionisios Vrochides; Chengli Shen; Michele Molinari; David A Geller; Allan Tsung Journal: World J Surg Date: 2020-03 Impact factor: 3.352
Authors: Okker D Bijlstra; Alexander Broersen; Timo T M Oosterveer; Robin A Faber; Friso B Achterberg; Rob Hurks; Mark C Burgmans; Jouke Dijkstra; J Sven D Mieog; Alexander L Vahrmeijer; Rutger-Jan Swijnenburg Journal: Life (Basel) Date: 2022-04-30
Authors: Mirhasan Rahimli; Aristotelis Perrakis; Mihailo Andric; Jessica Stockheim; Mareike Franz; Joerg Arend; Sara Al-Madhi; Mohammed Abu Hilal; Andrew A Gumbs; Roland S Croner Journal: Cancers (Basel) Date: 2022-07-11 Impact factor: 6.575
Authors: Alberto Brolese; Marta Rigoni; Alessio Pasquale; Giovanni Viel; Marco Brolese; Francesco Antonio Ciarleglio Journal: Front Oncol Date: 2022-09-28 Impact factor: 5.738